ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung - 
66340003 Teva Pharma AG
Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung09.11.2017
  09.11.2017
Reslizumab (R03DX08) 
WHO-DDD 
03.04.50. 
03.04.50. 
B  
Yes 
IP 
567.21Yes
    
10 %668.20
7680663400039Biotechnologika
7558001 
Composition
reslizumabum 100 mg, saccharum, natrii acetas trihydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 1.41 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Reslizumabum100mg / 10ml
BAG: Active AgentDose
Reslizumabum100 mg
 
Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Saccharum
 
Source
Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home